Your browser doesn't support javascript.
loading
Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia.
Matthews, Andrew H; Perl, Alexander E; Luger, Selina M; Loren, Alison W; Gill, Saar I; Porter, David L; Babushok, Daria V; Maillard, Ivan P; Carroll, Martin P; Frey, Noelle V; Hexner, Elizabeth O; Martin, Mary Ellen; McCurdy, Shannon R; Stadtmauer, Edward A; Paralkar, Vikram R; Bruno, Ximena Jordan; Hwang, Wei-Ting; Margolis, David; Pratz, Keith W.
Afiliación
  • Matthews AH; Division of Hematology-Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA; and.
  • Perl AE; Division of Hematology-Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA; and.
  • Luger SM; Division of Hematology-Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA; and.
  • Loren AW; Division of Hematology-Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA; and.
  • Gill SI; Division of Hematology-Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA; and.
  • Porter DL; Division of Hematology-Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA; and.
  • Babushok DV; Division of Hematology-Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA; and.
  • Maillard IP; Division of Hematology-Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA; and.
  • Carroll MP; Division of Hematology-Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA; and.
  • Frey NV; Division of Hematology-Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA; and.
  • Hexner EO; Division of Hematology-Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA; and.
  • Martin ME; Division of Hematology-Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA; and.
  • McCurdy SR; Division of Hematology-Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA; and.
  • Stadtmauer EA; Division of Hematology-Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA; and.
  • Paralkar VR; Division of Hematology-Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA; and.
  • Bruno XJ; Division of Hematology-Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA; and.
  • Hwang WT; Department of Biostatistics, Epidemiology and Informatics, Perlman School of Medicine, Philadelphia, PA.
  • Margolis D; Department of Biostatistics, Epidemiology and Informatics, Perlman School of Medicine, Philadelphia, PA.
  • Pratz KW; Division of Hematology-Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA; and.
Blood Adv ; 6(13): 3997-4005, 2022 07 12.
Article en En | MEDLINE | ID: mdl-35507945
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Azacitidina / Leucemia Mieloide Aguda Tipo de estudio: Observational_studies Aspecto: Patient_preference Límite: Aged / Humans Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Azacitidina / Leucemia Mieloide Aguda Tipo de estudio: Observational_studies Aspecto: Patient_preference Límite: Aged / Humans Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article